US Is Home to More Than 18 Million Cancer Survivors
There were more than 18 million cancer survivors in the United States at the beginning of this year, according to new data.
There were more than 18 million cancer survivors in the United States at the beginning of this year, according to new data.
Bridging therapy before ASCT improved event-free survival for patients with stable metastatic disease at the end of induction.
Hispanic children had inferior overall survival despite receiving the same treatment as their peers.
Nearly 70% of patients had at least 1 potentially actionable therapeutic target.
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
The risk of breakthrough SARS-CoV-2 infections was highest for liver cancer and lowest for thyroid cancer.
At the start of the pandemic, there was an immediate 34.3% decline in the estimated mean cancer incidence volume.
Radioiodine after thyroidectomy did not improve outcomes in patients with low-risk thyroid cancer.
When compared with chemotherapy or targeted therapy, peptide receptor radionuclide therapy significantly prolonged progression-free survival.
Researchers hypothesized that a rising number of thyroid cancer rates in adults with obesity in may also imply an increase in thyroid cancer rates in children.